DST regulates cisplatin resistance in colorectal cancer via PI3K/Akt pathway
DST plays a crucial role in limiting CRC progression and overcoming DDP resistance, suggesting potential for targeted CRC therapies.
Authors
- Xueting Deng (ORCID: https://orcid.org/0000-0002-9657-5030)
- Jianwei Yu (ORCID: https://orcid.org/0000-0003-4861-0257)
- Xiaoliang Lin (ORCID: https://orcid.org/0000-0002-5761-0307)
- Lixin Xie (ORCID: https://orcid.org/0009-0006-8117-2067)
- Sisi Guo
- Xueqin Lin
- Dong Lin (ORCID: https://orcid.org/0009-0007-1409-4051)
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1093/jpp/rgae104
- Citations
- 3
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 1.27
Funders
- Fujian Medical University